Neisseria gonorrhoeae is an urgent public health threat due to rapidly increasing incidence and 29 antibiotic resistance. In contrast with the trend of increasing resistance, clinical isolates that 30 have reverted to susceptibility regularly appear, prompting questions about which pressures 31 compete with antibiotics to shape gonococcal evolution. Here, we used genome-wide 32 association on the largest collection of N. gonorrhoeae isolates to date (n=4882) to identify loss-33 of-function (LOF) mutations in the efflux pump mtrCDE operon as a mechanism of increased 34 antibiotic susceptibility and demonstrate that these mutations are overrepresented in cervical 35 isolates relative to urethral isolates (odds ratio (OR) = 3.74, 95% CI [1.98-6.70]). In support of a 36 model in which pump expression incurs a fitness cost in this niche, cervical isolates were also 37 enriched relative to urethral isolates in LOF mutations in the mtrCDE activator mtrA (OR = 8.60,) and in farA, a subunit of the FarAB efflux pump (OR = 6.25, 95% CI [3.90-39 9.83]). In total, approximately 1 in 3 cervical isolates (36.4%) contained a LOF mutation in either 40 the efflux pump components mtrC or farA or the activator mtrA. Our findings extend beyond N. 41 gonorrhoeae to other Neisseria: mtrC LOF mutations are rare (<1%) in the primarily 42 nasopharyngeal-colonizing N. meningitidis in a collection of 14,798 genomes but enriched in a 43 heterosexual urethritis-associated lineage (8.6%, p = 9.90×10 -5 ), indicating that efflux pump 44 downregulation contributes broadly to the adaptation of pathogenic Neisseria to the female 45 urogenital tract. Overall, our findings highlight the impact of integrating microbial population 46 genomics with host metadata and demonstrate how host environmental pressures can lead to 47 increased antibiotic susceptibility. 48 49 50 51
Introduction
genome supervised learning algorithms to predict azithromycin resistance 23 . MIC variance 85 explained by known resistance mutations was also low for ceftriaxone (adjusted R 2 = 0.719) but 86 higher for ciprofloxacin (adjusted R 2 = 0.944), with 1.52% and 2.19% of strains, respectively, 87 exhibiting two dilutions or lower reported MICs compared to predictions, similarly indicating 88 unexplained susceptibility. The predictive modeling results therefore suggested unknown 89 modifiers that promote susceptibility for multiple classes of antibiotics in N. gonorrhoeae. of 4882 genomes based on 68697 SNPs ( Supplementary Table 1 ) was annotated with binarized 97 resistance (ciprofloxacin) or decreased susceptibility (azithromycin, ceftriaxone) values. 98
Annotation rings are listed in order of ciprofloxacin (purple), ceftriaxone (blue), and azithromycin 99 (pink) from innermost to outermost. Branch length represents total number of substitutions after 100 removal of predicted recombination. 101 102
Microbial genome-wide association identifies a variant that contributes to susceptibility 103 in the operon encoding the MtrCDE efflux pump 104
To identify novel antibiotic susceptibility loci in an unbiased manner, we conducted a bacterial 105 genome-wide association study (GWAS) . We used a linear mixed model framework to control 106 for population structure, and we used unitigs from genome assemblies to capture SNPs, indels, 107 and accessory genome elements [24] [25] [26] . We performed a GWAS on the sequences of 4463 108 isolates with associated azithromycin MICs using a Bonferroni-corrected significance threshold 109 of 2.97×10 -7 . The linear mixed model adequately controlled for population structure 110 ( Supplementary Figure 1) , and the proportion of phenotypic MIC variance attributable to 111 genotype (i.e., narrow-sense heritability) estimated by the linear mixed model was high (h 2 = 112 0.97). In line with this, we observed highly significant unitigs with positive effect sizes 113 corresponding to the known resistance substitutions C2611T and A2059G (E. coli numbering) in 114 the 23S ribosomal RNA gene as positive controls (Figure 2 ) 27 . The next most significant variant 115 was a unitig associated with increased susceptibility that mapped to mtrC (β, or effect size, = -116 2.80, 95% CI [-3.04, -2.56]; p-value = 3.30×10 -109 ). Overexpression of the mtrCDE efflux pump 117 operon has been shown to decrease gonococcal susceptibility to a range of hydrophobic acids 118 and antimicrobial agents 4,28 , and conversely, knockout of the pump results in multi-drug 119 hypersusceptibility 29 . To assess whether this mtrC variant was associated with increased 120 susceptibility to other antibiotics, we performed GWAS for ceftriaxone (for which MICs were 121 available from 4090 isolates) and for ciprofloxacin (4105 isolates). We recovered known 122 ceftriaxone resistance mutations including recombination in the penA gene and ciprofloxacin 123 resistance substitutions in DNA gyrase (gyrA). In agreement with the known pleiotropic effect of 124 the MtrCDE efflux pump 29 , we observed the same mtrC unitig at genome-wide significance 125 associated with increased susceptibility to both ceftriaxone (β = -1.15, 95% CI [-1.32, -0.98]; p-126 value = 2.84×10 -38 ) and ciprofloxacin (β = -1.30, 95% CI [-1.55, -1.05]; p-value = 1.25×10 -23 ) 127 ( Figure 2 ). Across all three drugs, heritability estimates for this mtrC variant were comparable to 128 that of prevalent major resistance determinants (azithromycin h 2 : 0.323; ceftriaxone h 2 : 0.199; 129 clinical gonococcal isolates hypersensitive to erythromycin were shown to have mutations 137 mapping to this locus 31 . To directly test the hypothesis that the two base pair deletion also 138 contributed to increased susceptibility for the panel of antibiotics we examined, we 139 complemented the mutation in a clinical isolate belonging to the multidrug-resistant lineage ST-140 1901 32 and observed significant increases in MICs for all three antibiotics, as predicted by the 141 Table 2 We searched for additional mtrC loss-of-function (LOF) mutations and found six clinical isolates 158 with genomes encoding indels outside of the dinucleotide hexarepeat that also were associated 159 with increased susceptibility ( Supplementary Figure 2A ). Ten isolates that had acquired the two 160 base pair deletion also have a two base pair insertion elsewhere in mtrC that restores the 161 original coding frame, suggesting that loss of MtrC function may be reverted by further mutation 162 or recombination ( Supplementary Figure 2A ). In line with this, mtrC LOF mutations have 163 emerged numerous times throughout the phylogeny ( Supplementary Figure 3) , indicative of 164 possible repeated gains and losses of a dinucleotide in the hexarepeat region due to DNA 165 polymerase slippage 33 . In total, including all strains with mtrC frameshift mutations and 166 excluding revertants, we identified 185 isolates (3.79%) that encoded a LOF allele of mtrC. 167
GWAS (Supplementary
Presence of the mtrC LOF mutation in isolates with known resistance markers was correlated 168 with significantly reduced MICs ( Supplementary Figure 4) , and inclusion of mtrC LOF mutations 169 in our linear model increased adjusted R 2 values (azithromycin: 0.681 to 0.739; ceftriaxone: 170 0.719 to 0.738; ciprofloxacin: 0.944 to 0.947), decreased the proportion of strains with 171 unexplained susceptibility (azithromycin: 5.49% to 3.09%; ceftriaxone: 1.51% to 1.15%; 172 ciprofloxacin: 2.19% to 1.80%), and significantly improved model fit (p < 2.2×10 -16 for all three 173 antibiotics; Likelihood-ratio χ 2 test for nested models). mtrC LOF strains were identified in 28 of 174 the 66 countries surveyed and ranged in isolation date from 1998 to 2017. Our results 175 demonstrate that a relatively common mechanism of gonococcal acquired antibiotic 176 susceptibility is a two base pair deletion in mtrC and that such mutations are globally and 177 temporally widespread. 178 179
Loss of the MtrCDE efflux pump is associated with cervical infection 180
The MtrCDE pump has been demonstrated to play a critical role in gonococcal survival in the 181 presence of human neutrophils and in the female murine genital tract model of gonococcal 182 infection, and overexpression of mtrCDE results in substantial fitness benefits for dealing with 183 both antimicrobial and environmental pressures 34-37 . The relative frequency of the mtrC LOF 184 mutations we observe (occurring in approximately 1 in every 25 isolates) thus seems unusual 185 for a mutation predicted to be deleterious for human infection. mtrC LOF strains do not grow 186 more or less quickly in vitro than mtrC wild-type strains, indicating that this mutation does not 187 confer a simple fitness benefit due to reduced energetic cost 31, 34 . Instead, we hypothesized that 188 there are unique environments that select for non-functional efflux pump. 189
190
We aggregated patient-level metadata across included studies on sex partner preferences and 191 anatomical site of infection. Sex of sex partner and mtrC genotypic information was available for 192 1975 isolates from individual patients. There was a significant association between mtrC LOF 193 and sex of sex partners (p = 0.04021; Fisher's exact test) ( Figure 3a ), and mtrC LOF occurred 194 more often in isolates from men who have sex with women (MSW) (28/626, 4.47%) compared 195 to isolates from men who have sex with men (MSM) (31/1189, 2.61%) (OR = 1.75, 95% CI 196 [1.00-3.04], p = 0.037; Fisher's exact test). To understand whether anatomical selective 197 pressures contributed to this enrichment, we analyzed the site of infection and mtrC genotypic 198 information available for 2730 isolates. mtrC LOF mutations were significantly associated with 199 site of infection (p = 6.49×10 -5 ; Fisher's exact test) and were overrepresented particularly in 200 cervical isolates: 16 out of 129 (12.4%) cervical isolates contained an mtrC LOF mutation 201 compared to 82 out of 2249 urethral isolates (3.65%; OR = 3.74, 95% CI [1.98-6.70], p = 202 4.71×10 -5 ; Fisher's exact test), 3 out of 106 pharyngeal isolates (2.83%; OR = 4.83, 95% CI 203 [1.33-26.63], p = 0.00769; Fisher's exact test), and 4 out of 246 rectal isolates (1.63%; OR = 204 8.52, 95% CI [2.67-35.787], p = 2.39×10 -5 ; Fisher's exact test) ( Figure 3b ). Because our meta-205 analysis collection comprises datasets potentially biased by preferential sampling for drug-206 resistant strains, we validated our epidemiological associations on a set of 2186 sequenced 207
isolates, corresponding to all cultured isolates of N. gonorrhoeae in the state of Victoria, 208
Australia in 2017 38 . We again observed significant associations between mtrC LOF and sex of 209 sex partner (p = 0.0180; Fisher's exact test) as well as anatomical site of infection (p = 0.0256; 210
Fisher's exact test) ( Supplementary Figure 5 primarily male urethral specimens found only four isolates with the 11-bp deletion (0.43%) 40 , 242 seemingly in agreement with the in vivo importance of mtrA. However, in our global meta-243 analysis dataset, 362/4882 isolates (7.41%) were predicted to be mtrA LOF, of which the 244 majority (357/362, 98.6%) were due to the 11-bp deletion. Of all 4882 isolates, 268 (5.49%) had 245 mtrA LOF mutations in non-mtrCDE overexpression backgrounds (as defined by the absence of 246 known mtrR promoter or coding sequence mutations or mtrCDE mosaic alleles) and therefore 247 not epistatically masked. We repeated our epidemiological associations on these mtrA LOF 248 strains without concurrent overexpression mutations and observed highly significant 249 associations with reported patient sex of sex partner (p = 1.81×10 -11 ; Fisher's exact test) and 250 site of infection (p = 1.64×10 -12 ; Fisher's exact test) ( Figure 3 Phylogenetic analysis showed that the distribution of mtrA LOF differed from that of mtrC LOF 263 with fewer introductions but more sustained transmission and that the two mutations were 264 Figure 2C) . farA LOF 286 mutations were associated with patient sex of sex partner (p = 5.06×10 -10 ; Fisher's exact test) 287 and site of infection (p = 1.76×10 -12 ; Fisher's exact test) and overrepresented in cervical 288 isolates: 33 out of 129 (25.6%) cervical isolates contained a farA LOF mutation compared to 289 117 out of 2246 urethral isolates (5.21%; OR = 6.25, 95% CI [3.90-9.83], p = 3.24×10 -13 ; 290
Fisher's exact test), 3 out of 106 pharyngeal isolates (2.83%; OR = 11.70, 95% CI [3.50-61.61], 291 p = 3.80×10 -7 ; Fisher's exact test), and 12 out of 246 rectal isolates (4.88%; OR = 6.66, 95% CI 292 overlapped with that of mtrA LOF mutations and indicated sustained transmission 297 ( Supplementary Figure 3) . We did not observe frequent LOF mutations in the sodium gradient-298 dependent MATE family efflux pump NorM 44 or in the ATP-dependent ABC family pump 299 MacAB 45 ( Supplementary Table 3 ). The prevalence and cervical enrichment of farA LOF 300 mutations and the relative rarity of LOF mutations in other non-proton motive force-driven 301 pumps suggests that cytoplasmic acidification may be a mechanism by which the female 302 urogenital tract selects for efflux pump loss. interruption of 'GC' dinucleotide repeats, predicted to result in a lower mutation rate 48 , and the 318 relative rarity of mtrC LOF mutations suggests that efflux pump loss is not generally adaptive in 319 N. meningitidis. However, a urogenitally-adapted meningococcal lineage has recently emerged 320 in the US associated with outbreaks of non-gonococcal urethritis in heterosexual patients 49-51 . In 321 isolates from this lineage, the prevalence of mtrC LOF mutations was 18/207 (8.70%), 322 substantially higher than typical N. meningitidis and comparable to the prevalence of 323 gonococcal mtrC LOF mutations in MSW in our global dataset (4.47%). We compared the 324 frequency of mtrC LOF mutations in the urogenital lineage to geographically and genetically 325 matched isolates (i.e., all publicly available PubMLST ST-11 North American isolates) and 326 observed a significant difference in prevalence (18 out of 207 or 8.70% versus 2 out of 248 or 327 0.81%; OR = 10.74, 95% CI [2.52-96.56], p = 9.90×10 -5 ; Fisher's exact test). Most mtrC LOF 328 mutations occurred due to the same hexarepeat two base pair deletion that we previously 329 observed for N. gonorrhoeae, and in line with this, mtrC LOF in this urogenital lineage arose 330 multiple times independently similarly to gonococcal mtrC LOF mutations (Figure 4 , 331 Supplementary Figure 3) . farA LOF mutations were not observed in this meningococcal lineage. 332
We conclude that MtrCDE efflux pump LOF is rare in typical meningococcal strains that inhabit 333 the oropharynx but elevated in frequency in a unique urogenitally-adapted lineage circulating in 334 heterosexuals, indicative of potential ongoing adaptation to the cervical niche. Our results 335 suggest that efflux pump loss is broadly adaptive for cervical colonization across pathogenic 336 In an era in which widespread antimicrobial pressure has led to the emergence of extensively 350 drug-resistant N. gonorrhoeae 52 , isolates that appear to have reverted to susceptibility still 351 arise 9,10 , demonstrating that antibiotic and host environmental pressures interact to shape the 352 evolution of N. gonorrhoeae. Here, we showed that frameshift-mediated truncations in the genital tract. We hypothesized that the mechanism by which this occurs is through increased 359 cytoplasmic acidification in anaerobic conditions 41 and demonstrated that LOF mutations in 360 farA, encoding a subunit of the other proton motive force-driven pump FarAB, were likewise 361 enriched in cervical isolates. mtrC and farA LOF mutations primarily occurred in short 362 homopolymeric sequences and thus may occur via phase variation at a frequency higher than 363 baseline mutation rate, similar to other resistance suppressor mutations 53 . In total, 36.4% of 364 cervical isolates in the global dataset and 32.6% in the Australian dataset contained a LOF 365 mutation in either mtrC, farA, or mtrA, indicating that efflux pump downregulation via multiple 366 genetic mechanisms is prevalent in cervical infection. Despite significant associations only a 367 proportion of cervical isolates exhibited these LOF genotypes, suggesting variation in cervix-368 associated pressures or indicating that cervical culture specimens were obtained before niche 369 pressures could select for pump downregulation. Furthermore, while the cervix is the primary 370 site of infection and source for culture in women, the selective pressures at play may include 371 other sites more broadly in the female genital tract and may be influenced by the presence of 372 other microbial species both pathogenic and commensal. While antibiotic use for gonorrhea in 373 men and women may differ due to variation in rates of symptomatic infections, differences in 374 antibiotic use could not explain the associations we observed for the non-antibiotic substrate 375 efflux pump farAB or the increased frequency of mtrC LOF mutations in urogenitally-adapted 376 meningococci. 377
378
Our model extended to the other pathogenic Neisseria species, N. meningitidis, in that a 379 urogenital clade transmitting in primarily heterosexual populations appeared to be undergoing 380 further urogenital adaptation via the same mtrC frameshift mutation that was most commonly observed for N. gonorrhoeae. In the absence of data on cases of cervicitis, we hypothesized 382 that for this meningococcal lineage, efflux pump LOF emerged in the female urogenital tract 383
and was transmitted to heterosexual men resulting in the enrichment we observed. Efflux 384 pumps are common across Gram-negative bacteria 54 , and their loss may be a general 385 adaptive strategy for species that face similar pressures as N. gonorrhoeae and urogenitally-386 adapted N. meningitidis. In support of this, clinical isolates of Pseudomonas aeruginosa with 387 truncations in genes homologous to mtrC 55,56 and antibiotic hypersensitivity have been 388 obtained from cystic fibrosis patients, in whom the thick mucus in airway environments can 389 exhibit increased acidity and decreased oxygen availability 57,58 . 390
391
Our results also suggest potential therapeutic avenues for addressing the emergence of Figure 4) . 400
401
In summary, by analysis of population genomics and patient clinical data, we have shown that 402 pathogenic Neisseria can use multiple avenues of efflux pump perturbation as an adaptive 403 strategy to respond to host environmental pressures and illustrate how these host pressures 404 may result in increased antibiotic susceptibility in N. gonorrhoeae. 405
Methods 406 407 Genomics pipeline: Reads for isolates with either associated azithromycin, ciprofloxacin, or 408 ceftriaxone MIC metadata were downloaded from datasets listed in Supplementary Table 1 . 409
Reads were inspected using FastQC 410 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and removed if GC content 411 diverged notably from expected values (approximately 52-54%) or if base quality was 412 systematically poor. We mapped read data to the NCCP11945 reference genome (RefSeq 413 accession: NC_011035.1) using BWA-MEM (version 0.7.17-r1188) 62,63 and deduplicated reads 414 using Picard (version 2.8.0) (https://github.com/broadinstitute/picard). BamQC in Qualimap 415 (version 2.2.1) 64 was run to identify samples with less than 70% of reads aligned or samples 416 with less than 40X coverage, which were discarded. We used Pilon (version 1.16) 65 to call 417 variants with mindepth set to 10 and minmq set to 20 and generated pseudogenomes from 418
Pilon VCFs by including all PASS sites and alternate alleles with AF > 0.9; all other sites were 419 assigned as 'N'. Samples with greater than 15% of sites across the genome missing were also 420 excluded. We created de novo assemblies using SPAdes (version 3.12.0) 66 and quality filtered 421 contigs to ensure coverage greater than 10X, length greater than 500 base pairs, and total 422 genome size approximately equal to the FA1090 genome size (2.0 to 2.3 Mbp). We annotated 423 assemblies with Prokka (version 1.13) 67 , and clustered core genes using Roary (version 424 3.12) 68 and core intergenic regions using piggy (version 1.2) 69 . A recombination-corrected 425 phylogeny of all isolates was constructed by running Gubbins (version 2.3.4) on the aligned 426 pseudogenomes and visualized in iTOL (version 4.4.2) 70-72 . All isolates with associated 427 metadata and accession numbers are listed in Supplementary Tables 5 and 6 . 428 429 Resistance allele calling: Known resistance determinants in single-copy genes were called 430 by identifying expected SNPs in the pseudogenomes. For categorizing mosaic alleles of mtr, 431
we ran BLASTn (version 2.6.0) 73 on the de novo assemblies using a query sequence from 432 FA1090 (Genbank accession: NC_002946.2) comprising the mtr intergenic promoter region 433 and mtrCDE. BLAST results were aligned using MAFFT (version 7.450) 74 and clustered into 434 distinct allelic families using FastBAPS (version 1.0.0) 75 . We confirmed that horizontally-435 transferred mtr alleles associated with resistance from prior studies 5 corresponded to distinct 436 clusters in FastBAPS. A similar approach was used to cluster penA alleles after running 437
BLASTn with a penA reference sequence from FA1090. Variant calling in the multi-copy 23S 438 rRNA locus was done by mapping to a modified NCCP11945 reference genome containing 439 only one copy of the 23S rRNA and analyzing variant allele frequencies 76 . We identified 440 truncated MtrR proteins using Prokka annotations, and mutations in the mtr promoter region 441 associated with upregulation of mtrCDE (A deletion and TT insertion in inverted repeat, mtr 442 120) using an alignment of the mtr promoter from piggy output. and in or near the highly variable pilE (encoding pilus subunit) or piiC (encoding opacity protein 471 family) genes were excluded, as were unitigs less than twenty base pairs in length. Due to 472 redundancy and linkage, variants will be spanned by multiple overlapping unitigs with similar 473 frequencies and p-values. For ease of interpretation, we grouped unitigs within 50 base pairs 474 of each other and represented each cluster by the most significant unitig. Unitigs with allele 475 frequency greater than 50% were also excluded as they represented the majority allele. Unitig 476 clusters were then annotated by gene or adjacent genes for unitigs mapping to intergenic 477 regions and further analyzed for predicted functional effect relative to the WHO F reference 478 genome in Geneious Prime (version 2019.2.1). 479 480 Identifying LOF and upregulation alleles: To identify predicted LOF alleles of efflux pump 481 proteins, we ran BLASTn on the de novo assemblies using a query sequence from FA1090 482 (reference genome FA19 was used for mtrA). Sequences that were full-length or 483 approximately full-length (+/-5 nucleotides) beginning with expected start codons were 484 translated using Biopython 78 . Peptides shorter than 90% of the expected full-length size of the 485 protein were further analyzed in Geneious Prime to identify the nucleotide mutations resulting 486 in predicted LOF. We called mtrCDE overexpression status by identifying the presence of any 487 of the known mtrR promoter mutations, MtrR coding sequence mutations, and mosaic mtrCDE 488 alleles. 489 490 Experimental validation: N. gonorrhoeae culture was conducted on GCB agar (Difco) plates 491 supplemented with 1% Kellogg's supplements 79 at 37°C in a 5% CO2 atmosphere. 492
Antimicrobial susceptibility testing was conducted on GCB agar supplemented with 1% 493 IsoVitaleX (Becton Dickinson) using Etests (bioMérieux) at 37°C in a 5% CO2 atmosphere. We 494 selected a clinical isolate (NY0195) from the multidrug-resistant lineage ST-1901 32 that 495 contained an mtrC LOF mutation mediated by a two base pair hexarepeat deletion and 496 confirmed via Etests that its MIC matched, within one dilution, its reported MIC. Isolate 497 NY0195 contained mosaic penA allele XXXIV conferring cephalosporin reduced susceptibility 498 and the gyrA S91F substitution conferring ciprofloxacin resistance 9 . We complemented the 499 mtrC LOF mutation in this strain by transforming it via electroporation 79 with a 2kb PCR 500 product containing a Neisserial DNA uptake sequence and an in-frame mtrC allele, obtained 501 by colony PCR from a neighboring isolate (GCGS0759). After obtaining transformants by selecting on an azithromycin 0.05 μg/mL GCB plate supplemented with Kellogg's supplement, 503 we confirmed successful transformation by Sanger sequencing of the mtrC gene. No 504 spontaneous mutants on azithromycin 0.05 μg/mL plates were observed after conducting 505 control transformations in the absence of GCGS0759 mtrC PCR product. We conducted 506 antimicrobial susceptibility testing in triplicate using Etests, assessing statistical significance 507 between parental and transformant MICs by a two-sample t-test. 508 509 Metadata analysis: Patient metadata were collected from supplementary tables where 510 available and values standardized across datasets using a common ontology (i.e., for site of 511 infection, classification as urethra, rectum, pharynx, or cervix). Fisher's exact test in R (version 512 3.5.1) was used to infer whether there was nonrandom association between mtrC LOF 513 presence and either anatomical site of infection or sex of sex partner. For sex of sex partner 514 analysis, isolates cultured from multiple sites on the same patient were counted as only one 515 data point. 516 517 Meningococcal mtrC analysis: mtrC alleles from N. meningitidis assembled genomes were 518 downloaded from PubMLST (n=14798; accessed 2019-09-03) by setting (species = "Neisseria 519 meningitidis"), filtering by (Sequence bin size >= 2 Mbp), and exporting sequences for Locus 520 "NEIS1634" 80 . mtrC LOF alleles were identified as described above. We generated a core-521 genome maximum likelihood phylogeny of all North American ST-11 N. meningitidis strains 522 from PubMLST (n=456; accessed 2019-09-03) rooted with meningococcal reference genome 523 MC58 (Genbank accession: AE002098.2) using Roary (version 3.12) and annotated it using 
